Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

Clinical trial NCT00131261 · COMPLETED

Trial details

NCT number: NCT00131261
Sponsor: Valerio Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2005-01-01
Primary completion: 2007-01-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.